RxDoctor Payments Data

Alice Slavens

Psychiatric/Mental Health · Fort Smith, ARNPI 1326289547

Payments from drug & device makers

$1,893in general payments, 2019–2025

Across 108 payments — averaging $17.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$497
  • Alkermes, Inc.$285
  • Neurocrine Biosciences, Inc.$214
  • Otsuka America Pharmaceutical, Inc.$204
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$149
  • Johnson & Johnson$124
  • plus $420 from 6 others

What the payments were for

  • Food & beverage$1,893100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,893 in reported general payments places this provider in the 70th percentile of 359 psychiatric/mental health providers in Arkansas.

See all psychiatric/mental health providers in Arkansas

Medicare billing

Part B allowed, 2024
$52,800
Medicare patients
154
Services billed
537

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate207$640,189
AristadaAripiprazole Lauroxil51$161,131
Abilify MaintenaAripiprazole36$103,942
VraylarCariprazine Hcl54$77,848
RexultiBrexpiprazole35$63,540
Aripiprazole433$45,754
Paliperidone ErPaliperidone155$31,197
Chlorpromazine Hcl90$18,968
Lurasidone Hcl84$13,480
Asenapine Maleate24$12,470
Clozapine94$8,950
Venlafaxine Hcl ErVenlafaxine Hcl196$8,626
Olanzapine372$8,215
Buspirone Hcl638$8,002
Quetiapine Fumarate414$7,085

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$124$640,189207 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$204$167,48271 claims
Alkermes, Inc.Aristada$285$161,13151 claims
AbbVieVraylar$497$77,84854 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 359 psychiatric/mental health providers in Arkansas.

Other psychiatric/mental health in Fort Smith

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →